General Announcement::ASX:TLX; Nasdaq:TLX: FDA accepts BLA and grants priority review for Zircaix

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
26-Feb-2025 07:01:44
Status
New
Announcement Sub Title
ASX:TLX; Nasdaq:TLX: FDA accepts BLA and grants priority review for Zircaix
Announcement Reference
SG250226OTHR0CS3
Submitted By (Co./ Ind. Name)
Genevieve Ryan
Designation
Company Secretary
Effective Date and Time of the event
26/02/2025 17:00:00
Description (Please provide a detailed description of the event in the box below)
ASX:TLX; Nasdaq:TLX: FDA accepts BLA and grants priority review for Zircaix

Attachments

20250226 Zircaix BLA Acceptance vFINAL.pdf
Total size =144K